BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18706512)

  • 21. Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: insights on ADAM function.
    Liu H; Shim AH; He X
    J Biol Chem; 2009 Oct; 284(42):29077-86. PubMed ID: 19692335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (Make) stick and cut loose--disintegrin metalloproteases in development and disease.
    Tousseyn T; Jorissen E; Reiss K; Hartmann D
    Birth Defects Res C Embryo Today; 2006 Mar; 78(1):24-46. PubMed ID: 16622847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADAMs and protein disulfide isomerase: the key to regulated cell-surface protein ectodomain shedding?
    Bass R; Edwards DR
    Biochem J; 2010 May; 428(3):e3-5. PubMed ID: 20504280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Three-dimensional domain architecture of the ADAM family proteinases].
    Takeda S
    Tanpakushitsu Kakusan Koso; 2009 Oct; 54(13):1754-9. PubMed ID: 19827608
    [No Abstract]   [Full Text] [Related]  

  • 25. Autoactivation of human ADAM8: a novel pre-processing step is required for catalytic activity.
    Hall T; Leone JW; Wiese JF; Griggs DW; Pegg LE; Pauley AM; Tomasselli AG; Zack MD
    Biosci Rep; 2009 Aug; 29(4):217-28. PubMed ID: 18811590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Metalloproteinase Cocktail from the Venom of
    Futai E; Kawasaki H; Sato S; Daoudi K; Hidaka M; Tomita T; Ogawa T
    Toxins (Basel); 2023 Aug; 15(8):. PubMed ID: 37624257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the ancestral recruitment of metalloproteinases into the venom of snakes.
    Casewell NR
    Toxicon; 2012 Sep; 60(4):449-54. PubMed ID: 22406471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAMs family and relatives in cardiovascular physiology and pathology.
    Zhang P; Shen M; Fernandez-Patron C; Kassiri Z
    J Mol Cell Cardiol; 2016 Apr; 93():186-99. PubMed ID: 26522853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms.
    Apte SS
    J Biol Chem; 2009 Nov; 284(46):31493-7. PubMed ID: 19734141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteoglycan degradation by the ADAMTS family of proteinases.
    Stanton H; Melrose J; Little CB; Fosang AJ
    Biochim Biophys Acta; 2011 Dec; 1812(12):1616-29. PubMed ID: 21914474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship studies on ADAM protein-integrin interactions.
    Lu X; Lu D; Scully MF; Kakkar VV
    Cardiovasc Hematol Agents Med Chem; 2007 Jan; 5(1):29-42. PubMed ID: 17266546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2).
    Shieh HS; Mathis KJ; Williams JM; Hills RL; Wiese JF; Benson TE; Kiefer JR; Marino MH; Carroll JN; Leone JW; Malfait AM; Arner EC; Tortorella MD; Tomasselli A
    J Biol Chem; 2008 Jan; 283(3):1501-1507. PubMed ID: 17991750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple non-catalytic ADAMs are novel integrin α4 ligands.
    Wang L; Hoggard JA; Korleski ED; Long GV; Ree BC; Hensley K; Bond SR; Wolfsberg TG; Chen J; Zeczycki TN; Bridges LC
    Mol Cell Biochem; 2018 May; 442(1-2):29-38. PubMed ID: 28913673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An ADAM metalloprotease is a Cry3Aa Bacillus thuringiensis toxin receptor.
    Ochoa-Campuzano C; Real MD; Martínez-Ramírez AC; Bravo A; Rausell C
    Biochem Biophys Res Commun; 2007 Oct; 362(2):437-42. PubMed ID: 17714689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disintegrin and Metalloproteinases (ADAMs [A Disintegrin and Metalloproteinase] and ADAMTSs [ADAMs With a Thrombospondin Motif]) in Aortic Aneurysm.
    Kilic T; Okuno K; Eguchi S; Kassiri Z
    Hypertension; 2022 Jul; 79(7):1327-1338. PubMed ID: 35543145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of the ADAMTS family, pharmaceutical targets of the future.
    Tortorella MD; Malfait F; Barve RA; Shieh HS; Malfait AM
    Curr Pharm Des; 2009; 15(20):2359-74. PubMed ID: 19601837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of the ADAM and ADAMTS families.
    Andreini C; Banci L; Bertini I; Elmi S; Rosato A
    J Proteome Res; 2005; 4(3):881-8. PubMed ID: 15952735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shedding light on ADAM metalloproteinases.
    Huovila AP; Turner AJ; Pelto-Huikko M; Kärkkäinen I; Ortiz RM
    Trends Biochem Sci; 2005 Jul; 30(7):413-22. PubMed ID: 15949939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Snake Venom Metalloproteinases (SVMPs): A structure-function update.
    Olaoba OT; Karina Dos Santos P; Selistre-de-Araujo HS; Ferreira de Souza DH
    Toxicon X; 2020 Sep; 7():100052. PubMed ID: 32776002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions.
    Giebeler N; Zigrino P
    Toxins (Basel); 2016 Apr; 8(4):122. PubMed ID: 27120619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.